Loading…
Successful pharmaceutical-grade streptozotocin (STZ)-induced hyperglycemia in a conscious tethered baboon (Papio hamadryas) model
Background Non‐human primate (NHP) diabetic models using chemical ablation of β‐cells with STZ have been achieved by several research groups. Chemotherapeutic STZ could lead to serious adverse events including nephrotoxicity, hepatotoxicity, and mortality. Methods We implemented a comprehensive ther...
Saved in:
Published in: | Journal of medical primatology 2015-08, Vol.44 (4), p.202-217 |
---|---|
Main Authors: | , , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Background
Non‐human primate (NHP) diabetic models using chemical ablation of β‐cells with STZ have been achieved by several research groups. Chemotherapeutic STZ could lead to serious adverse events including nephrotoxicity, hepatotoxicity, and mortality.
Methods
We implemented a comprehensive therapeutic strategy that included the tether system, permanent indwelling catheter implants, an aggressive hydration protocol, management for pain with IV nubain and anxiety with IV midazolam, moment‐by‐moment monitoring of glucose levels post‐STZ administration, and continuous intravenous insulin therapy.
Results
A triphasic response in blood glucose after STZ administration was fully characterized. A dangerous hypoglycemic phase was also detected in all baboons. Other significant findings were hyperglycemia associated with low levels of plasma leptin, insulin and C‐peptide concentrations, hyperglucagonemia, and elevated non‐esterified fatty acids (NEFA) concentrations.
Conclusions
We successfully induced frank diabetes by IV administering a single dose of pharmaceutical‐grade STZ safely and without adverse events in conscious tethered baboons. |
---|---|
ISSN: | 0047-2565 1600-0684 |
DOI: | 10.1111/jmp.12182 |